Statutory Instruments

HEALTH SERVICES (PRESCRIPTION CHARGES) REGULATIONS 2017

These Regulations provide for a reduction in the prescription charge from €2.50 to €2.00 per item, and for a reduction in the monthly cap from €25.00 to €20.00, per person or family. These Regulations revoke Health Services (Prescription Charges) Regulations 2013 (S.I. No. 437 of 2013). HEALTH SERVICES (PRESCRIPTION CHARGES) REGULATIONS 2017    

EUROPEAN COMMUNITIES (HYGIENE OF FOODSTUFFS) (AMENDMENT) REGULATIONS 2018

These Regulations give effect to Commission Regulation (EU) 2016/238 of 19 February 2016 amending the Annex to Regulation (EU) No. 579/2014 granting derogation from certain provisions of Annex II to Regulation (EC) No. 852/2004 of the European Parliament and of the Council as regards the transport of liquid oils and fats by sea. These Regulations

EUROPEAN COMMUNITIES (OFFICIAL CONTROLS ON THE IMPORT OF FOOD OF NON-ANIMAL ORIGIN) (AMENDMENT) REGULATIONS 2018

These Regulations give effect to Commission Implementing Regulation (EU) 2017/2298 of 12 December 2017 amending Regulation (EC) No. 669/2009 as regards the increased level of official controls on imports of certain food of nonanimal origin. These Regulations amend the European Communities (Official Controls on the Import of Food of Non-Animal Origin) Regulations 2010 (S.I. No.

HEALTH AND SOCIAL CARE PROFESSIONALS (AMENDMENT) ACT 2017 (COMMENCEMENT) ORDER 2017

This Order will commence the Health and Social Care Professionals (Amendment) Act 2017 (No. 32 of 2017) with effect from 20th of December 2017. The effect of the Order will be amend certain provisions of the Health and Social Care Professionals Act 2005 to address gaps relating to the appointment of professional members to the

HEALTH SERVICES (DRUG PAYMENT SCHEME) REGULATIONS 2017

These Regulations provide for a reduction in the monthly co-payment threshold, to €134 in any calendar month, for approved prescribed medicines or other items supplied under the Drug Payment Scheme. These Regulations ensure that, where expenditure on approved prescribed medicines or other items supplied under the Drug Payment Scheme exceeds €134 in any calendar month,

EUROPEAN UNION (MEDICAL DEVICES AND IN VITRO DIAGNOSTIC MEDICAL DEVICES) REGULATIONS 2017

The purpose of these Regulations is to designate the Health Products Regulatory Authority as the competent authority responsible for enforcing the following EU Regulations: — Regulation (EU) 2017/745 of the European Parliament and of the Council of 5 April 2017 on medical devices, and — Regulation (EU) 2017/746 of the European Parliament and of the

Health (Out-Patient Charges) Regulations 2017 S.I. No. 548 of 2017

These Regulations provide for the addition of an exemption of a relevant participant (within the meaning of section 2 of the Redress for Women’s Resident in Certain Institutions Act 2015) (Magdalen Women) from the €100 charge for out-patient services provided at an emergency department, an accident and emergency department, a casualty department, a minor injury unit, an urgent care

MISUSE OF DRUGS (DESIGNATION) (AMENDMENT) ORDER 2017 S.I. No. 533 of 2017

The purpose of this Order is to amend the Misuse of Drugs (Designation) Order 2017 by inserting into Schedule 1 to that Order the following: 3,4-Dichloro-N-(2-dimethylamino-cyclohexyl)-N-methyl-benzamide (otherwise known as U-47700); Ethyl phenyl(piperidin-2-yl)acetate (otherwise known as Ethylphenidate); [1-(5-Fluoropentyl)-1H-indol-3-yl](2,2,3,3-tetramethylcyclopropyl)methanone (otherwise known as XLR-11); and N-Methyl-1-(thiophen-2-yl)propan-2-amine (otherwise known as Methiopropamine). This Order may be cited as the Misuse

MISUSE OF DRUGS (AMENDMENT) REGULATIONS 2017 S.I. No. 532 of 2017

The purpose of these Regulations is to amend the Misuse of Drugs Regulations 2017 by inserting into Schedule 1 to those Regulations the following: 3,4-Dichloro-N-(2-dimethylamino-cyclohexyl)-N-methyl-benzamide (otherwise known as U-47700); Ethyl phenyl(piperidin-2-yl)acetate (otherwise known as Ethylphenidate); [1-(5-Fluoropentyl)-1H-indol-3-yl](2,2,3,3-tetramethylcyclopropyl)methanone (otherwise known as XLR-11); and N-Methyl-1-(thiophen-2-yl)propan-2-amine (otherwise known as Methiopropamine). These Regulations may be cited as the Misuse of

Page 1/79